CP3’s Dr. Tom Radomski received a new VA Merit grant to lead EVOLV-Rx VA, a study aimed at reducing low-value prescribing in VA Community Living Centers. The project will use an EVOLV-Rx dashboard to support pharmacists in making deprescribing recommendations.